Physicians Total Care, Inc. (USA) has no DMF, CEP or site registration linked in our records. 33 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Physicians Total Care, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/physicians-total-care-inc

Overview

Physicians Total Care, Inc. is a privately held pharmaceutical company focused on providing prescription medications to healthcare professionals. The company specializes in meeting the unique medication needs of physicians and clinics. It aims to enhance patient care by offering a broad range of therapeutic solutions.

Therapeutic areas

FDA compliance signals

33 FDA enforcement records linked to this company.

  • recall — Class III2014-11-12

    Failed Tablet/Capsule Specifications: Affected lot numbers may contain chipped or broken tablets.

  • recall — Class II2014-11-12

    CGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not manufactured with good manufacturing practices.

  • recall — Class II2014-01-01

    Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.

  • recall — Class II2013-08-07

    Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.

  • recall — Class III2013-06-12

    Labeling: Incorrect or Missing Lot and/or Expiration Date; This recall is being initiated because the lot number and expiration date on the tube may not be legible.

  • recall — Class II2013-06-12

    Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.

  • recall — Class III2013-06-05

    Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

  • recall — Class III2013-05-15

    Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).

  • recall — Class III2013-05-08

    Presence of Foreign Tablets/Capsules: One bottle of Percocet 10/325 mg was found to contain a tablet of Endocet 10/25 mg, the generic form.

  • recall — Class II2013-04-03

    Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API.

  • recall — Class II2013-04-03

    Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API.

  • recall — Class II2013-03-27

    Subpotent; 15 month stability (by mfr)

  • warning_letter2013-01-10

    FDA Warning Letter (drug product)

  • recall — Class II2012-12-26

    Presence of Particulate Matter: glass delamination

  • recall — Class III2012-12-19

    Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

  • recall — Class III2012-12-19

    Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

  • recall — Class III2012-12-19

    Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

  • recall — Class II2012-07-04

    Impurities/Degradation Products; Product is being recalled due to the potential of not meeting the Impurity C specification through the product shelf life

  • recall — Class II2012-06-27

    Chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.

  • recall — Class I2012-06-27

    Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.

  • recall — Class I2012-06-27

    Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.

  • recall — Class II2012-06-20

    Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.

  • 4832012-02-24

    Written procedures not established/followed

  • 4832012-02-24

    Mfg / Processing Operations Area

  • 4832012-02-24

    Procedures to be written and followed

  • 4832012-02-24

    Written procedures followed

  • 4832012-02-24

    No written record of investigation

  • 4832012-02-24

    Penicillin processing area not kept separate

  • 4832010-09-15

    Items to cover on annual reviews

  • 4832010-09-15

    Training , Education , Experience overall

  • 4832010-09-15

    Signature and checking of records -- 2 persons

  • 4832010-09-15

    Calibration - at intervals, written program, remedial action

  • warning_letter2009-03-30

    FDA Warning Letter (drug product)

For suppliers

Is this Physicians Total Care, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.